Medicine
Pro re nata
Macular degeneration
Ranibizumab
Ophthalmology
Logistic regression
Choroid
Fluorescein angiography
Choroidal neovascularization
Proportional hazards model
Retrospective cohort study
Internal medicine
Bevacizumab
Visual acuity
Retina
Chemotherapy
Physics
Optics
